Fierce Pharma: Novartis Switzerland has launched a pilot program with its own employees which includes a custom version of the Migraine Buddy program from Healint

According to Danny Bar-Zohar, the global head of neuroscience development at Novartis, real-world experience is valuable not only for future drug development and broader disease management approaches but also for current educational, tele-coaching and digital solutions to help migraine sufferers with daily challenges.